Corum Group eked out some revenue growth in the first half of 2022, but board expects better (and are looking for a new CEO).

We don’t know what it means, exactly, but it’s rarely a positive sign in the short term.

Corum is at the start of a new journey. At 4.2x healthcare revenue, the market doesn’t believe the story. So Corum needs to prove it can grow.

Corum and Rightcrowd report increasing cash burn in their quarterly cashflow and 8Common has reported a material contract win.

Corum Group improved its cash burn during the quarter, but shareholders might have to wait a while for organic top line growth to resurface.

Part 1 focusses on smaller, illiquid, relatively unknown micro-caps that could fall sharply as bond rates rise.

These little companies are each hovering around breakeven, and if a few things go right, they could end up soaring…